|
SAP30L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.58095758706622E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.75004455371663E-12 |
| Normal-vs-Stage2 |
8.199200E-04 |
| Normal-vs-Stage3 |
4.08200000000525E-05 |
| Normal-vs-Stage4 |
4.253500E-02 |
| Stage1-vs-Stage2 |
6.152200E-01 |
| Stage1-vs-Stage3 |
6.119000E-01 |
| Stage1-vs-Stage4 |
5.619800E-01 |
| Stage2-vs-Stage3 |
9.591800E-01 |
| Stage2-vs-Stage4 |
8.728800E-01 |
| Stage3-vs-Stage4 |
8.289200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.1094237467878E-14 |
| Normal-vs-AfricanAmerican |
3.66750000002636E-06 |
| Normal-vs-Asian |
2.036100E-04 |
| Caucasian-vs-AfricanAmerican |
1.000630E-01 |
| Caucasian-vs-Asian |
9.688400E-01 |
| AfricanAmerican-vs-Asian |
6.307200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62914126633495E-12 |
| Normal-vs-Female |
5.90059999999726E-05 |
| Male-vs-Female |
1.555530E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.78090000524378E-08 |
| Normal-vs-Extreme_Weight |
1.63846713974181E-12 |
| Normal-vs-Obese |
1.4498000000529E-06 |
| Normal-vs-Extreme_Obese |
5.69139999573309E-08 |
| Normal_Weight-vs-Extreme_Weight |
5.380800E-01 |
| Normal_Weight-vs-Obese |
2.076600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.895800E-01 |
| Extreme_Weight-vs-Obese |
2.633500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.078600E-01 |
| Obese-vs-Extreme_Obese |
2.118200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.0280999995782E-07 |
| Normal-vs-Age(41-60Yrs) |
3.06190000021189E-08 |
| Normal-vs-Age(61-80Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(81-100Yrs) |
1.559170E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.809200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.735800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.860200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.539400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.930380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.092400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.85962356624714E-13 |
| Normal-VS-Type2 PRCC |
4.83590945066226E-12 |
| Normal-VS-KIRP CIMP |
1.13759999975649E-07 |
| Normal-VS-Unclassified PRCC |
2.876300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.887400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.428800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.282600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.172400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.494800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.456600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.96249716267039E-11 |
| Normal-vs-N1 |
8.103700E-03 |
| Normal-vs-N2 |
1.69286999999185E-05 |
| N0-vs-N1 |
5.215800E-02 |
| N0-vs-N2 |
5.311600E-01 |
| N1-vs-N2 |
1.987610E-01 |
|
|
